News | Interventional Radiology | March 19, 2021

Non-invasive option has quicker recovery and shorter hospital stays in 12-year sample

Many women suffering significant postpartum bleeding continue to receive hysterectomies, rather than uterine artery embolization (UAE), despite evidence that UAE results in reduced hospital stays and costs, and offers an opportunity to preserve fertility, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting

March 19, 2021 — Many women suffering significant postpartum bleeding continue to receive hysterectomies, rather than uterine artery embolization (UAE), despite evidence that UAE results in reduced hospital stays and costs, and offers an opportunity to preserve fertility, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting.

“Giving birth has become increasingly dangerous for women in the U.S., and postpartum hemorrhage is a leading cause of the loss of life related to childbirth,” said Janice M. Newsome, M.D., FSIR, associate professor, Department of Radiology and Imaging Sciences at Emory University School of Medicine and a lead author of the study. “All patients should have consistent access to a treatment that is safer, has an easier recovery and could preserve their ability to continue to have children.”

In a review of nearly 10 million hospital births between 2005 and 2017, researchers found the most common intervention was transfusion, but removal of the uterus through hysterectomy was used 60% more often to manage bleeding than UAE, a minimally invasive procedure that uses real-time imaging to release tiny particles into uterine arteries to control the bleeding. Hysterectomy was twice as common as embolization in Hispanic patients, and also more common in rural and nonteaching urban hospitals, in the South and among Medicaid and self-paying patients.

Prolonged hospital stays of more than 14 days were twice as likely in patients who had hysterectomies and the procedure resulted in $18,000 higher hospital charges.

“Postpartum hemorrhage can occur quickly, and effective treatment options should be readily available to every woman having a child in the United States,” said Newsome. “For hospitals that have IR services available, this can be accomplished by creating a concrete care plan for new mothers who are at higher risk of dangerous bleeding during childbirth.”

Newsome envisions creating postpartum hemorrhage response teams, similar to other trauma teams, that would train together and develop response protocols, so that they are better able to identify risk factors of postpartum hemorrhage and ensure the right staff are on hand for delivery to respond quickly and save mothers’ lives before it gets to the point of needing radical surgery.

Researchers used the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database, which tracks every hospital admission in the United States, and examined the results of significant postpartum bleeding, which occurred in 3.1 percent of live births.

For more information: www.sirmeeting.org


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now